CTRI/2023/03/050313
Recruiting
Phase 2
Evaluation of efficacy and safety of Beone Capsule as an immunity & energy booster for healthy body & mind in healthy individuals - A Randomized, Double Blind, Placebo controlled, Multi centric, Comparative, Prospective, Interventional, Clinical Study - NI
upin Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- upin Ltd
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Healthy individuals
- •2\. Subjects (for 18 years and above) who have taken at least one dose of
- •COVID\-19 vaccine.
- •3\. Subjects who are ready to provide written informed consent and who are ready to willingly participate and follow the protocol requirements of the clinical study.
Exclusion Criteria
- •1\. Pregnant and Lactating females
- •2\. Subjects who have been confirmed of having COVID\-19 and have been isolated for its treatment. Subjects having recently (3 months) suffered and recovered of COVID\-19 will also be excluded from the study
- •3\. Known cases of Diabetes
- •4\. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
- •5\. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis and Cancer etc.
- •6\. Subjects taking steroid treatment and or any kind of immunosuppressive therapy
- •7\. Subjects participating in any other clinical study or having participated in any other study 3 months prior to screening in the present study.
- •8\. Subjects having a past history of allergy to Beone Capsule or any of its ingredients
- •9\. Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
To evaluate the efficacy and safety of Longvida capsule in the patients suffering from knee osteoarthritis.CTRI/2015/07/006061Pharmanza Herbal PvtLtd
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for Facial ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Facial ContouringTCTR20230516008ASTRACO MEDICAL NETWORKS LTD.39
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for cheek and nasolabial fold ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Cheek and nasolabial fold ContouringTCTR20230515001ASTRACO MEDICAL NETWORKS LTD.39
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital RejuvenatioHealthy PatientBipolar Radiofrequency-Assisted Lipolysis,Adjustable-depth fractional microneedle bipolar radiofrequency,periorbital RejuvenationTCTR20230417001ASTRACO MEDICAL NETWORKS LTD.38
Completed
Phase 4
Role of Capsule Diacea in DiabetesCTRI/2018/01/011256MB LIFESCIENCES PVT LTD50